ArticleThe American journal of clinical nutrition2025
High concentrations of polyunsaturated n-3 fatty acids in serum are inversely associated with risk of future incident venous thromboembolism - the HUNT cohort study.
Article in The American journal of clinical nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- SerumFrontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies on the association between n-3 (ω-3) polyunsaturated fatty acids (n-3 PUFAs) and risk of venous thromboembolism (VTE), mainly derived from self-reported dietary intake of n-3 PUFAs, have shown mixed results.
objectivesThe aim of this cohort study was to investigate the association between measured serum n-3 PUFA concentrations and risk of first-ever VTE.
methodsThe present cohort (N = 17,087) was derived from the third survey of the Trøndelag Health Study and consisted of individuals aged ≥20 y without previous VTE. Serum n-3 PUFA concentrations were measured in blood drawn at inclusion (2006-2008) using a nuclear magnetic resonance metabolomic platform (Nightingale), and participants were followed until an objectively verified first-ever VTE event, death, migration, or 31 December, 2019. Cox regression was used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs).
resultsDuring a median follow-up of 12 y, 340 experienced an incident VTE event. Participants with n-3 PUFA concentrations in the highest tertile had 28% lower relative risk of VTE (HR: 0.72; 95% CI: 0.54, 0.96) than those with n-3 PUFAs in the lowest tertile in age-adjusted analysis. The inverse association was most pronounced for provoked VTE (HR: 0.62; 95% CI: 0.44, 0.87) and deep vein thrombosis (HR: 0.61; 95% CI: 0.40, 0.93). HRs remained virtually unaffected after further adjustment for sex, body mass index, and history of cardiovascular disease or cancer at baseline.
conclusionsOur finding of an inverse association between serum n-3 PUFA concentrations and VTE suggest that a diet enriched with n-3 PUFAs might protect against future VTE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.